Business
BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
Presentation will be Web cast live LAVAL, QC, Nov. 6 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: B...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\nPresentation will be Web cast live\n\n\nLAVAL, QC, Nov. 6 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX:\nBLU) announces today that on Tuesday, November 11, Mr. Gary Schmid, President\nand Chief Executive Officer of OVOS Natural Health Inc., a wholly owned\nsubsidiary of BELLUS Health, will present a review of ongoing pharmaceutical\nand nutraceutical activities at the Rodman and Renshaw 10th Annual Healthcare\nConference to be held at the New York Palace Hotel in New York, NY. The\npresentation will take place at 4:55 P.M. ET.\n\n\nThe live Web cast of BELLUS Health's presentation (audio and visual) can\nbe accessed at http://www.wsw.com/webcast/rrshq14/blus. A replay of the\npresentation will begin three (3) hours after the actual presentation time,\nand will be available until November 18, 2008. Please access the Web cast\napproximately 15 minutes before the presentation is scheduled to begin.\n\n\nAbout BELLUS Health\n\n\nBELLUS Health is a global health company focused on the development and\ncommercialization of products to provide innovative health solutions to\naddress critical unmet needs.\n\n\nTo contact BELLUS Health\n\n\nFor additional information on BELLUS Health and its drug development\nprograms, please call the Canada and United States toll-free number 1 877 680\n4500 or visit the Web Site at www.bellushealth.com.\n\n\nCertain statements contained in this news release, other than statements\nof fact that are independently verifiable at the date hereof, may constitute\nforward-looking statements. Such statements, based as they are on the current\nexpectations of management, inherently involve numerous risks and\nuncertainties, known and unknown, many of which are beyond BELLUS Health\nInc.'s (formerly known as Neurochem Inc.) control. Such risks include but are\nnot limited to: the impact of general economic conditions, general conditions\nin the pharmaceutical and/or nutraceutical industry, changes in the regulatory\nenvironment in the jurisdictions in which the BELLUS Health Group does\nbusiness, stock market volatility, fluctuations in costs, and changes to the\ncompetitive environment due to consolidation, that actual results may vary\nonce the final and quality-controlled verification of data and analyses has\nbeen completed, as well as other risks disclosed in public filings of BELLUS\nHealth ...